INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 176 filers reported holding INSMED INC in Q2 2019. The put-call ratio across all filers is 1.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,887,327 | +166.2% | 74,747 | +122.5% | 0.00% | +200.0% |
| Q2 2023 | $708,937 | +20.3% | 33,599 | -2.8% | 0.00% | 0.0% |
| Q1 2023 | $589,472 | -13.8% | 34,574 | +1.1% | 0.00% | -50.0% |
| Q4 2022 | $683,598 | -30.0% | 34,213 | -24.6% | 0.00% | 0.0% |
| Q3 2022 | $977,000 | +28.4% | 45,360 | +16.9% | 0.00% | 0.0% |
| Q2 2022 | $761,000 | -38.4% | 38,808 | -26.6% | 0.00% | 0.0% |
| Q1 2022 | $1,235,000 | -2.9% | 52,836 | +12.8% | 0.00% | 0.0% |
| Q4 2021 | $1,272,000 | -3.0% | 46,849 | -1.9% | 0.00% | -33.3% |
| Q3 2021 | $1,311,000 | +137.9% | 47,762 | +144.6% | 0.00% | +200.0% |
| Q2 2021 | $551,000 | -81.0% | 19,525 | -77.1% | 0.00% | -85.7% |
| Q1 2021 | $2,893,000 | +41.4% | 85,124 | +38.1% | 0.01% | +40.0% |
| Q4 2020 | $2,046,000 | +189.4% | 61,635 | +179.5% | 0.01% | +150.0% |
| Q3 2020 | $707,000 | -37.6% | 22,053 | -46.5% | 0.00% | -50.0% |
| Q2 2020 | $1,133,000 | +140.0% | 41,214 | +39.5% | 0.00% | +100.0% |
| Q1 2020 | $472,000 | -36.0% | 29,543 | -4.7% | 0.00% | 0.0% |
| Q4 2019 | $737,000 | +38.8% | 31,000 | +2.4% | 0.00% | +100.0% |
| Q3 2019 | $531,000 | -50.5% | 30,264 | -27.9% | 0.00% | -75.0% |
| Q2 2019 | $1,072,000 | -1.6% | 41,969 | +11.8% | 0.00% | 0.0% |
| Q1 2019 | $1,089,000 | +51.9% | 37,556 | -6.6% | 0.00% | +33.3% |
| Q4 2018 | $717,000 | +31.6% | 40,189 | +49.0% | 0.00% | +50.0% |
| Q3 2018 | $545,000 | +62.7% | 26,964 | +89.9% | 0.00% | +100.0% |
| Q2 2018 | $335,000 | -0.3% | 14,196 | -4.8% | 0.00% | 0.0% |
| Q1 2018 | $336,000 | -48.1% | 14,919 | -28.1% | 0.00% | -50.0% |
| Q4 2017 | $647,000 | +627.0% | 20,749 | +632.1% | 0.00% | – |
| Q3 2017 | $89,000 | – | 2,834 | +11708.3% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 24 | -100.0% | 0.00% | -100.0% |
| Q3 2015 | $1,838,000 | +10111.1% | 98,974 | +13665.5% | 0.02% | – |
| Q2 2015 | $18,000 | +5.9% | 719 | -11.1% | 0.00% | – |
| Q1 2015 | $17,000 | +240.0% | 809 | +59.6% | 0.00% | – |
| Q4 2014 | $5,000 | – | 507 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
| SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
| NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
| Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
| Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
| EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
| Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
| Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |